Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
15.4 BRL | -6.37% | -2.84% | -11.80% |
May. 08 | Transcript : Wilson Sons S.A., Q1 2024 Earnings Call, May 08, 2024 | |
May. 08 | EARNINGS: International Biotechnology bullish; Andrews Sykes profit up | AN |
Sales 2024 * | 469M 2.46B | Sales 2025 * | 544M 2.86B | Capitalization | 1.29B 6.78B |
---|---|---|---|---|---|
Net income 2024 * | 69M 362M | Net income 2025 * | 77M 404M | EV / Sales 2024 * | 3.79 x |
Net Debt 2024 * | 484M 2.54B | Net Debt 2025 * | 464M 2.43B | EV / Sales 2025 * | 3.23 x |
P/E ratio 2024 * |
18.7
x | P/E ratio 2025 * |
16.6
x | Employees | 3,800 |
Yield 2024 * |
2.69% | Yield 2025 * |
3.03% | Free-Float | 43.48% |
Latest transcript on Wilson Sons S.A.
1 day | -6.37% | ||
1 week | -2.84% | ||
1 month | -8.33% | ||
3 months | -10.72% | ||
6 months | -0.52% | ||
Current year | -11.80% |
Managers | Title | Age | Since |
---|---|---|---|
Chief Executive Officer | 55 | 15-12-31 | |
Chairman | 64 | 93-12-31 | |
Chief Operating Officer | 67 | 79-12-31 |
Members of the board | Title | Age | Since |
---|---|---|---|
William Salomon
BRD | Director/Board Member | 66 | - |
Chairman | 64 | 93-12-31 | |
Director/Board Member | 74 | 90-12-31 |
Name | Weight | AuM | 1st Jan change | Investor Rating |
---|---|---|---|---|
0.00% | 34 M€ | +3.86% | - |
Date | Price | Change | Volume |
---|---|---|---|
24-05-31 | 15.4 | -0.96% | 1,968,200 |
24-05-29 | 15.55 | -0.96% | 546,000 |
24-05-28 | 15.7 | -0.95% | 677,400 |
24-05-27 | 15.85 | -.--% | 215,700 |
24-05-24 | 15.85 | -0.44% | 424,800 |
Delayed Quote Sao Paulo, May 31, 2024 at 04:10 pm EDT
More quotesEPS Revisions
Quarterly revenue - Rate of surprise
1st Jan change | Capi. | |
---|---|---|
-11.80% | 1.29B | |
+38.41% | 11.86B | |
+17.42% | 6.22B | |
+6.39% | 2.48B | |
+7.79% | 1.77B | |
+26.89% | 1.12B | |
+18.87% | 1.02B | |
-.--% | 996M | |
+8.62% | 683M | |
+24.67% | 639M |
- Stock Market
- Equities
- PORT3 Stock